New and recently US Food and Drug Administration (FDA)–approved tools to measure and monitor cognition aim to make in-office cognitive assessment faster and simpler. One of these is Cognivue (Cerebral Assessment Systems Inc), a computer-based tool designed to better and more easily assess, measure, and monitor brain function to detect early signs of dementia, according to a company press release issued in June at the time of FDA approval.